Loomis, Sayles & Company’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-205,798
| Closed | -$68.7M | – | 763 |
|
|
2024
Q3 | $68.7M | Buy |
205,798
+13,880
| +7% | +$4.63M | 0.09% | 92 |
|
|
2024
Q2 | $79M | Buy |
191,918
+33,144
| +21% | +$13.7M | 0.11% | 74 |
|
|
2024
Q1 | $64.2M | Sell |
158,774
-5,100
| -3% | -$2.06M | 0.09% | 94 |
|
|
2023
Q4 | $50.2M | Buy |
163,874
+1,345
| +0.8% | +$412K | 0.08% | 118 |
|
|
2023
Q3 | $39.4M | Sell |
162,529
-5,072
| -3% | -$1.23M | 0.07% | 142 |
|
|
2023
Q2 | $40.3M | Sell |
167,601
-1,542
| -0.9% | -$370K | 0.06% | 141 |
|
|
2023
Q1 | $31.8M | Buy |
169,143
+1,995
| +1% | +$375K | 0.06% | 170 |
|
|
2022
Q4 | $35.5M | Sell |
167,148
-72,528
| -30% | -$15.4M | 0.07% | 146 |
|
|
2022
Q3 | $37.7M | Sell |
239,676
-2,873
| -1% | -$452K | 0.08% | 131 |
|
|
2022
Q2 | $36.3M | Sell |
242,549
-16,593
| -6% | -$2.48M | 0.07% | 144 |
|
|
2022
Q1 | $42.4M | Buy |
259,142
+25,900
| +11% | +$4.24M | 0.06% | 158 |
|
|
2021
Q4 | $50.8M | Buy |
233,242
+139,767
| +150% | +$30.4M | 0.06% | 146 |
|
|
2021
Q3 | $17.7M | Buy |
+93,475
| New | +$17.7M | 0.02% | 317 |
|
|
2019
Q2 | – | Sell |
-481
| Closed | -$28K | – | 676 |
|
|
2019
Q1 | $28K | Buy |
481
+183
| +61% | +$10.7K | ﹤0.01% | 571 |
|
|
2018
Q4 | $16K | Sell |
298
-287
| -49% | -$15.4K | ﹤0.01% | 740 |
|
|
2018
Q3 | $35K | Sell |
585
-24
| -4% | -$1.44K | ﹤0.01% | 633 |
|
|
2018
Q2 | $26K | Sell |
609
-140
| -19% | -$5.98K | ﹤0.01% | 732 |
|
|
2018
Q1 | $26K | Hold |
749
| – | – | ﹤0.01% | 743 |
|
|
2017
Q4 | $27K | Hold |
749
| – | – | ﹤0.01% | 727 |
|
|
2017
Q3 | $24K | Buy |
749
+356
| +91% | +$11.4K | ﹤0.01% | 734 |
|
|
2017
Q2 | $11K | Buy |
393
+46
| +13% | +$1.29K | ﹤0.01% | 792 |
|
|
2017
Q1 | $10K | Hold |
347
| – | – | ﹤0.01% | 803 |
|
|
2016
Q4 | $13K | Buy |
+347
| New | +$13K | ﹤0.01% | 822 |
|